Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
Apple Turns 50: From Garage Startup to AI Crossroads 
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
STAVANGER, Norway, Dec. 11, 2015 (GLOBE NEWSWIRE) -- On behalf of Statoil (OSE: STL, NYSE:STO), DNB has on 10 December 2015 purchased 750,203 shares for use in the group's Share saving plan.
The shares have been acquired at a price of NOK 123.56 per share.
Before distribution to the employees, the Share saving plan has 11,433,066 shares.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
HUG#1972912
CONTACT: Hilde Merete Nafstad, SVP Investor Relations, mbl +47 95783911
Morten Sven Johannessen, VP Investor Relations USA, mbl +1 203 570
